3-148841864-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001871.3(CPB1):c.516C>A(p.Asp172Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0119 in 1,613,778 control chromosomes in the GnomAD database, including 140 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0092 ( 9 hom., cov: 33)
Exomes 𝑓: 0.012 ( 131 hom. )
Consequence
CPB1
NM_001871.3 missense
NM_001871.3 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: 0.190
Genes affected
CPB1 (HGNC:2299): (carboxypeptidase B1) Three different procarboxypeptidases A and two different procarboxypeptidases B have been isolated. The B1 and B2 forms differ from each other mainly in isoelectric point. Carboxypeptidase B1 is a highly tissue-specific protein and is a useful serum marker for acute pancreatitis and dysfunction of pancreatic transplants. It is not elevated in pancreatic carcinoma. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.01431182).
BP6
Variant 3-148841864-C-A is Benign according to our data. Variant chr3-148841864-C-A is described in ClinVar as [Benign]. Clinvar id is 3039545.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-148841864-C-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0122 (17807/1461486) while in subpopulation MID AF= 0.0321 (185/5768). AF 95% confidence interval is 0.0283. There are 131 homozygotes in gnomad4_exome. There are 8954 alleles in male gnomad4_exome subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPB1 | NM_001871.3 | c.516C>A | p.Asp172Glu | missense_variant | 6/11 | ENST00000282957.9 | NP_001862.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPB1 | ENST00000282957.9 | c.516C>A | p.Asp172Glu | missense_variant | 6/11 | 1 | NM_001871.3 | ENSP00000282957.4 |
Frequencies
GnomAD3 genomes AF: 0.00921 AC: 1402AN: 152174Hom.: 9 Cov.: 33
GnomAD3 genomes
AF:
AC:
1402
AN:
152174
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0108 AC: 2713AN: 251368Hom.: 20 AF XY: 0.0113 AC XY: 1537AN XY: 135846
GnomAD3 exomes
AF:
AC:
2713
AN:
251368
Hom.:
AF XY:
AC XY:
1537
AN XY:
135846
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0122 AC: 17807AN: 1461486Hom.: 131 Cov.: 30 AF XY: 0.0123 AC XY: 8954AN XY: 727012
GnomAD4 exome
AF:
AC:
17807
AN:
1461486
Hom.:
Cov.:
30
AF XY:
AC XY:
8954
AN XY:
727012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00919 AC: 1399AN: 152292Hom.: 9 Cov.: 33 AF XY: 0.00907 AC XY: 675AN XY: 74456
GnomAD4 genome
AF:
AC:
1399
AN:
152292
Hom.:
Cov.:
33
AF XY:
AC XY:
675
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
34
ALSPAC
AF:
AC:
43
ESP6500AA
AF:
AC:
13
ESP6500EA
AF:
AC:
117
ExAC
AF:
AC:
1304
Asia WGS
AF:
AC:
10
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CPB1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 27, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Benign
T;T;T
Polyphen
P;P;.
Vest4
MutPred
Loss of sheet (P = 0.302);Loss of sheet (P = 0.302);.;
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at